Roxana Rustomjee
Overview
Explore the profile of Roxana Rustomjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
2637
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Churchyard G, Kim P, Shah N, Rustomjee R, Gandhi N, Mathema B, et al.
J Infect Dis
. 2017 Nov;
216(suppl_6):S629-S635.
PMID: 29112747
Tuberculosis remains a global health problem with an enormous burden of disease, estimated at 10.4 million new cases in 2015. To stop the tuberculosis epidemic, it is critical that we...
12.
Mathema B, Andrews J, Cohen T, Borgdorff M, Behr M, Glynn J, et al.
J Infect Dis
. 2017 Nov;
216(suppl_6):S644-S653.
PMID: 29112745
Measuring tuberculosis transmission is exceedingly difficult, given the remarkable variability in the timing of clinical disease after Mycobacterium tuberculosis infection; incident disease can result from either a recent (ie, weeks...
13.
Auld S, Kasmar A, Dowdy D, Mathema B, Gandhi N, Churchyard G, et al.
J Infect Dis
. 2017 Nov;
216(suppl_6):S662-S668.
PMID: 29112744
High rates of tuberculosis transmission are driving the ongoing global tuberculosis epidemic, and there is a pressing need for research focused on understanding and, ultimately, halting transmission. The ongoing tuberculosis-human...
14.
Shah N, Kim P, Kana B, Rustomjee R
J Infect Dis
. 2017 Nov;
216(suppl_6):S627-S628.
PMID: 29112742
No abstract available.
15.
Chirehwa M, McIlleron H, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, et al.
Antimicrob Agents Chemother
. 2017 Jun;
61(8).
PMID: 28607022
Pyrazinamide is used in the treatment of tuberculosis (TB) because its sterilizing effect against tubercle bacilli allows the shortening of treatment. It is part of standard treatment for drug-susceptible and...
16.
Mthiyane T, Pym A, Dheda K, Rustomjee R, Reddy T, Manie S
Qual Life Res
. 2016 Jun;
25(12):3067-3076.
PMID: 27277213
Introduction: Assessment of patients receiving treatment for human immunodeficiency virus (HIV) and tuberculosis (TB) using a Health Related Quality of Life (HRQoL) instrument is important to get the subjective view...
17.
Chirehwa M, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, McIlleron H, et al.
Antimicrob Agents Chemother
. 2016 Apr;
60(5):3262.
PMID: 27107106
No abstract available.
18.
Zumla A, Rao M, Wallis R, Kaufmann S, Rustomjee R, Mwaba P, et al.
Lancet Infect Dis
. 2016 Apr;
16(4):e47-63.
PMID: 27036359
Despite extensive global efforts in the fight against killer infectious diseases, they still cause one in four deaths worldwide and are important causes of long-term functional disability arising from tissue...
19.
Wallis R, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori G, et al.
Lancet Infect Dis
. 2016 Apr;
16(4):e34-46.
PMID: 27036358
Tuberculosis is the leading infectious cause of death worldwide, with 9·6 million cases and 1·5 million deaths reported in 2014. WHO estimates 480,000 cases of these were multidrug resistant (MDR)....
20.
Rustomjee R, Zumla A
Infect Drug Resist
. 2015 Nov;
8:359-66.
PMID: 26604805
Tuberculosis (TB) remains a global emergency and is one of the most common infectious disease causes of death in developing countries. Current treatment regimens for multi-drug resistant TB are associated...